Periodontal repair in dogs: effect of recombinant human bone morphogenetic protein‐12 (rhBMP‐12) on regeneration of alveolar bone and periodontal attachment

Abstract Objectives: Recombinant human bone morphogenetic protein‐2 (rhBMP‐2) has been shown to stimulate alveolar bone and cementum formation in periodontal defects but not a functionally oriented periodontal ligament (PDL). Subcutaneous and intramuscular implants of BMP‐12 have been shown to induce tendon formation and ligament‐like tissue. The objective of this study was to evaluate rhBMP‐12 for periodontal regeneration, in particular PDL formation. Methods: Six young adult Hound Labrador mongrel dogs were used. Routine supraalveolar periodontal defects were created around the mandibular premolar teeth. Three animals received rhBMP‐12(0.04 mg/ml) in an absorbable collagen sponge (ACS) carrier vs. rhBMP‐12(0.2 mg/mL)/ACS in contralateral defects. Three animals received rhBMP‐12(1.0 mg/ml)/ACS vs. rhBMP‐2(0.2 mg/ml)/ACS (total implant volume/defect ∼1 ml). The animals were euthanized 8 weeks postsurgery and block biopsies were processed for histometric analysis. Results: Bone regeneration appeared increased in sites receiving rhBMP‐2/ACS compared to sites receiving rhBMP‐12/ACS. Cementum regeneration was similar comparing sites implanted with rhBMP‐2/ACS to sites implanted with rhBMP‐12/ACS. In contrast, sites receiving rhBMP‐12/ACS exhibited a functionally oriented PDL bridging the gap between newly formed bone and cementum whereas this was a rare observation in sites receiving rhBMP‐2/ACS. Ankylosis appeared increased in sites receiving rhBMP‐2/ACS compared to those receiving rhBMP‐12/ACS. Conclusions: The outcomes of this study suggest that rhBMP‐12 may have significant effects on regeneration of the PDL. Additional preclinical evaluation is needed to confirm these initial observations prior to clinical application.